Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer

• Main Authors: Farrhana Z. Firdaus (Author), Stacey Bartlett (Author), Waleed M. Hussein (Author), Lantian Lu (Author), Quentin Wright (Author), Wenbin Huang (Author), Ummey J. Nahar (Author), Jieru Yang (Author), Mattaka Khongkow (Author), Margaret Veitch (Author), Prashamsa Koirala (Author), Uracha R. Ruktanonchai (Author), Michael J. Monteiro (Author), Jazmina L. Gonzalez Cruz (Author), Rachel J. Stephenson (Author), James W. Wells (Author), Istvan Toth (Author), Mariusz Skwarczynski (Author)
• Format: Book
• Published: MDPI AG, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Human papilloma virus (HPV) is responsible for all cases of cervical cancer. While prophylactic vaccines are available, the development of peptide-based vaccines as a therapeutic strategy is still under investigation. In comparison with the traditional and currently used treatment strategies of chem...